our research

research

Cataract

A cataract is when the lens of the eye becomes cloudy (opacification) which leads to reduced vision and blindness if untreated

 

Child Eye Health

Detecting and managing eye conditions in children is essential to achieve eye health. Our research covers primary care, retinoblastoma and retinopathy of prematurity (RoP)

 

Corneal Infection

Corneal infections are a common sight-threatening eye emergency worldwide. Our research covers the epidemiology, diagnosis and treatment trials

 

Diabetic Retinopathy

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus and it affects 463 million people worldwide.

 

Equity

Equity in eye health aims to address the pervasive, unfair yet avoidable differences in eye health that exist between and within countries.

 

Glaucoma

Glaucoma is the most common irreversible cause of blindness globally but is difficult to identify and patients often present late, with advanced vision loss.

 

Health Systems

Health systems intersect with many areas of our research, particularly in the area of primary eye care integration

 

Mobile Health

mHealth offers the potential to better connect people to eye health services; in collaboration with Peek Vision we are developing and testing such systems

 

Ocular Surface Neoplasia

Ocular surface squamous neoplasia is a unilateral tumour of the eyeball arising at the junction of the cornea and conjunctiva. Later it invades the eye, orbit and brain.

Population-based Surveys

Surveys are crucial for defining population eye health needs, planning services and tracking progress; we support national comprehensive and rapid surveys.

a woman holds up a smartphone with an E acuity test showing on it

Refractive Error

Refractive error accounts for a large proportion of sight loss worldwide. Screening, diagnosis and provision of spectacles is key to improving sight for millions. 

 

Trachoma

Trachoma is the commonest infectious cause of blindness in the world. We do research on epidemiology, pathophysiology and clinical trials to improve control